Meta Stock: Record Growth, Negative Cash Flow – and the Price Sits on the Base Case
METAMeta Platforms, Inc.
DCF focus with Graham-Dodd
Gross margin of 81% (above 60%), no separately valuable profit segments – Reality Labs sits in the group DCF as a loss-maker. Result: DCF $325 / 643 / 1,024, Graham-Dodd $703–789.
WACC explained → · DCF valuation explained → · Terminal value explained → · Fair value explained →
After Q3: What the Oct 21 Report Shows
The analysis is dated Oct 23 and includes the Q3 report. The stock fell 7.0% the next day ($697.52 → $648.85) and closed Friday at $642.62 – just above the 20-day low. Key points:
- A clear beat. Revenue of $64.60bn (+26%) vs. $63.34bn consensus, adjusted EPS of $7.40 vs. $6.54. Ad impressions +10%, price per ad +14%, 3.64bn daily active people.
- Costs growing faster. 2026 total expenses of $175–179bn and capex of $135–145bn. Free cash flow turned to −$1.16bn in Q3.
- Legal risk. A $9.89bn provision for the settlement with 52 state attorneys general cuts GAAP EPS to $3.83; the framework runs up to about $18.59bn.
- Outlook and dates. Q4 revenue of $73–76bn (+22–27%). Fed decision on Oct 28, Class C stock dividend (effectively 2-for-1) effective Jan 19, 2027, Q4 results on Jan 27, 2027.
Verdict: Operationally a strong quarter; the market is punishing capex and legal costs. The $612–632 zone (SMA200, 61.8% Fibonacci, Elliott invalidation) is now the decisive test.
Fundamentals vs. Technicals
Fundamentals: revenue engine intact, FCF tipping
The reported operating margin fell from 40.1% to 20.1% over five quarters (adjusted Q3 around 35%), free cash flow from $11.17bn to −$1.16bn. TTM ROIC 18.1%, ROE 30.3%. Reality Labs lost $4.13bn in Q3; the loss is guided to fall to about $15bn in 2027. No buybacks in 2026 – capex comes first.
Technicals: damaged short term, intact long term
Price below the SMA50 ($662.61), just above the SMA200 ($631.68), RSI 36.9 and below the lower Bollinger Band – volume (+50%) confirms the sell-off. Weekly medium (SMA10 above SMA40) and long term (golden cross since Jun 21, 2024) remain up. 19% below the $793.02 all-time high.
Valuation: All Models at a Glance
| Model | Bear | Base | Bull | Base vs. price |
|---|---|---|---|---|
| DCF (FCF, WACC 9.9%) | $325 | $643 | $1,024 | +0.1% |
| Graham-Dodd (GAAP EPS $29.31 / adjusted ~$32.9) | $703 | $789 | – | +22.8% |
WACC: risk-free rate 4.96%, beta 1.19, equity risk premium 4.46% → cost of equity 10.25%, WACC 9.86%. Base: TTM revenue of $241.6bn; FCF margin 7.7% → 22 / 28 / 32% within five years; growth 10→4 / 15→5 / 20→6% p.a. over ten years; terminal 2.5 / 3 / 3%. The range is this wide because today's FCF margin is depressed by capex – what matters is whether it moves back toward 30%.
Key Chart Levels
Support 1: SMA200 ($631.68) and 20-day low ($639.69). Support 2: Elliott invalidation ($611.95) and 61.8% Fibonacci ($621.77). Resistance: SMA50 and 38.2% Fibonacci. Chart levels, not a trading recommendation.
Context Check (Macro)
With a beta of 1.19, Meta feels the rising nervousness ahead of the Fed and the US election: the VIX is at 19.8, about 25% above its 50-day average, though not yet a stress regime. A US 10-year yield of 4.96% raises the bar for returns on the AI investments.
The ad market is cyclical, and over twelve months Meta is down 11.2%, well behind Alphabet (+27.4%) – the market is pricing in the capex burden. Next dates: Fed decision on Oct 28, Q4 results on Jan 27, 2027.
The Devil's Advocate
“Fairly valued here means the market trusts Meta to return to a 28% FCF margin – and there is no evidence for that yet.”
Total expenses of up to $179bn and capex of up to $145bn push the reported operating margin down to 20.1%. Stock-based compensation costs another ~11% of revenue.
$9.89bn has been provisioned, but the settlement framework runs up to about $18.59bn – close to a full quarter of adjusted operating profit.
The daily Elliott count is counter-trend: invalidation below $611.95 (52.7%) is more likely than wave 5 toward $779.82 (43.7%). And analyst price targets (avg. $834) mostly predate the Q3 report.
Interactive DCF Calculator
| Item | Value | ||
|---|---|---|---|
Simplified model: TTM revenue of $241.6bn, growth fading linearly to 5% over 10 years, terminal 3%, FCF margin moving from 7.7% to the target within 5 years, 2.52bn shares. The net financial position is set so that the calculator reproduces the analysis base case ($643). Try it: at a 28% target margin, the $642.62 share price equals about 15% initial growth – if the margin drops to 22%, the value falls to about $505.
| Market cap | ~$1.62tn |
| P/E TTM / fwd | 22.0x / 18.6x |
| Alphabet / Tencent fwd | 20.8x / 12.0x |
| Op. margin Q3 adj. | ~35% |
| FCF Q3/26 | −$1.16bn |
| Capex 2026e | $135–145bn |
| ROIC TTM | 18.1% |
| Beta | 1.19 |
| 12M performance | −11.2% |
| Q4 results | Jan 27, 2027 |
The strongest finding of the week: for Meta, the weekly state "SMA10 above SMA40, neutral RSI" beat the baseline by +3.6 / +5.9 / +6.5 pp after 4/8/12 weeks (n = 444). The long-term state, by contrast, trails the baseline – due to the extremely strong early phase in 2012–2014, not a weak signal.
- Full QualiStocks research report (as of Oct 22, 2026)
- Prices & indicators: yfinance, close Oct 22, 2026; headline price: close Oct 23, 2026
- Fundamental and analyst data: Financial Modeling Prep
- Meta Q3/2026 report (Oct 21, 2026)
Position disclosure: at the time of publication, the author holds no position in META.
More analyses this week
Up 73% in twelve months and just below its all-time high. On earnings multiples in line with peers, but above the DCF base case – the market is pricing in a successful transition beyond Keytruda. Q3 results on Oct 29.
AWS grows 39% and the operating margin hits a record 13.9%. Our SOTP base case rises from $217 to $224. After hours (≈ $227), the price is only about 1% above it.
New analyses by email
Once a week: new analyses and updates on existing stocks. Free, unsubscribe anytime.